{"id":"https://openalex.org/W2160552893","doi":"https://doi.org/10.1093/cid/ciq160","title":"An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers","display_name":"An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers","alternate_titles":[],"publication_year":2011,"publication_date":"2011-02-15","ids":{"openalex":"https://openalex.org/W2160552893","doi":"https://doi.org/10.1093/cid/ciq160","mag":"2160552893","pmid":"https://pubmed.ncbi.nlm.nih.gov/21208909","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3060898"},"language":"en","primary_location":{"id":"doi:10.1093/cid/ciq160","doi":"https://doi.org/10.1093/cid/ciq160","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciq160","pdf_url":"https://academic.oup.com/cid/article-pdf/52/4/522/13802754/ciq160.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2160552893"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/cid/article-pdf/52/4/522/13802754/ciq160.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085088557","display_name":"Eva Van Braeckel","orcid":"https://orcid.org/0000-0002-7242-0747","observed_orcids":["https://orcid.org/0000-0002-7242-0747"]},"institutions":[{"id":"https://openalex.org/I2801227569","display_name":"Ghent University Hospital","ror":"https://ror.org/00xmkp704","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801227569"]},{"id":"https://openalex.org/I32597200","display_name":"Ghent University","ror":"https://ror.org/00cv9y106","country_code":"BE","type":"education","lineage":["https://openalex.org/I32597200"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eva Van Braeckel","raw_affiliation_strings":["Center for Vaccinology, Ghent University and Hospital, Ghent. Belgium","Center for Vaccinology, Ghent University and Hospital, Ghent"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Vaccinology, Ghent University and Hospital, Ghent. Belgium","institution_ids":["https://openalex.org/I2801227569","https://openalex.org/I32597200"]},{"raw_affiliation_string":"Center for Vaccinology, Ghent University and Hospital, Ghent","institution_ids":["https://openalex.org/I2801227569","https://openalex.org/I32597200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072080295","display_name":"Patricia Bourguignon","orcid":"https://orcid.org/0000-0003-0398-6293","observed_orcids":["https://orcid.org/0000-0003-0398-6293"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia Bourguignon","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034726124","display_name":"Marguerite Koutsoukos","orcid":"https://orcid.org/0000-0002-4174-8424","observed_orcids":["https://orcid.org/0000-0002-4174-8424"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marguerite Koutsoukos","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068491736","display_name":"Fr\u00e9d\u00e9ric Cl\u00e9ment","orcid":"https://orcid.org/0000-0002-2720-3655","observed_orcids":["https://orcid.org/0000-0002-2720-3655"]},"institutions":[{"id":"https://openalex.org/I2801227569","display_name":"Ghent University Hospital","ror":"https://ror.org/00xmkp704","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801227569"]},{"id":"https://openalex.org/I32597200","display_name":"Ghent University","ror":"https://ror.org/00cv9y106","country_code":"BE","type":"education","lineage":["https://openalex.org/I32597200"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fr\u00e9d\u00e9ric Clement","raw_affiliation_strings":["Center for Vaccinology, Ghent University and Hospital, Ghent"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Vaccinology, Ghent University and Hospital, Ghent","institution_ids":["https://openalex.org/I2801227569","https://openalex.org/I32597200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040449126","display_name":"Michel Janssens","orcid":"https://orcid.org/0000-0002-8800-9071","observed_orcids":["https://orcid.org/0000-0002-8800-9071"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michel Janssens","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039170447","display_name":"Isabelle Carletti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isabelle Carletti","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072039447","display_name":"Alix Collard","orcid":"https://orcid.org/0009-0004-3808-2109","observed_orcids":["https://orcid.org/0009-0004-3808-2109"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alix Collard","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019029049","display_name":"Marie\u2010Ange Demoiti\u00e9","orcid":"https://orcid.org/0009-0009-4021-2300","observed_orcids":["https://orcid.org/0009-0009-4021-2300"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie-Ange Demoiti\u00e9","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077029331","display_name":"G\u00e9rald Voss","orcid":"https://orcid.org/0000-0002-1984-5121","observed_orcids":["https://orcid.org/0000-0002-1984-5121"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gerald Voss","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056800707","display_name":"Geert G Leroux-Roels","orcid":"https://orcid.org/0000-0001-5968-2542","observed_orcids":["https://orcid.org/0000-0001-5968-2542"]},"institutions":[{"id":"https://openalex.org/I2801227569","display_name":"Ghent University Hospital","ror":"https://ror.org/00xmkp704","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801227569"]},{"id":"https://openalex.org/I32597200","display_name":"Ghent University","ror":"https://ror.org/00cv9y106","country_code":"BE","type":"education","lineage":["https://openalex.org/I32597200"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Geert Leroux-Roels","raw_affiliation_strings":["Center for Vaccinology, Ghent University and Hospital, Ghent"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Vaccinology, Ghent University and Hospital, Ghent","institution_ids":["https://openalex.org/I2801227569","https://openalex.org/I32597200"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103482999","display_name":"Lisa\u00a0M. McNally","orcid":"https://orcid.org/0009-0005-6769-5825","observed_orcids":["https://orcid.org/0009-0005-6769-5825"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa McNally","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5056800707"],"corresponding_institution_ids":["https://openalex.org/I2801227569","https://openalex.org/I32597200"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":{"value":4763,"currency":"USD","value_usd":4763},"fwci":2.1961,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.86669177,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"52","issue":"4","first_page":"522","last_page":"531"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-vaccine","display_name":"HIV-1 vaccine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/as01-adjuvant","display_name":"AS01 adjuvant","score":0.9430000185966492},{"id":"https://openalex.org/keywords/cd4-t-cell-responses","display_name":"CD4+ T cell responses","score":0.9670000076293945},{"id":"https://openalex.org/keywords/polyfunctional-t-cells","display_name":"polyfunctional T cells","score":0.878000020980835},{"id":"https://openalex.org/keywords/t-cell-cross-reactivity","display_name":"T cell cross-reactivity","score":0.7269999980926514},{"id":"https://openalex.org/keywords/reverse-transcriptase","display_name":"reverse transcriptase","score":0.8230000138282776},{"id":"https://openalex.org/keywords/gag-p24","display_name":"Gag p24","score":0.7760000228881836},{"id":"https://openalex.org/keywords/nef","display_name":"NEF","score":0.8679999709129333},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.7639999985694885},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.7481076121330261},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7034696340560913},{"id":"https://openalex.org/C2777704310","wikidata":"https://www.wikidata.org/wiki/Q7300322","display_name":"Reactogenicity","level":4,"score":0.7008095979690552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6218167543411255},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5775274634361267},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4777866303920746},{"id":"https://openalex.org/C2910359755","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"HIV Antigens","level":4,"score":0.46457135677337646},{"id":"https://openalex.org/C2780195530","wikidata":"https://www.wikidata.org/wiki/Q1479804","display_name":"HIV vaccine","level":4,"score":0.42377376556396484},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.42206400632858276},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3808039426803589},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.33346274495124817},{"id":"https://openalex.org/C2778190748","wikidata":"https://www.wikidata.org/wiki/Q7907956","display_name":"Vaccine trial","level":3,"score":0.2603793740272522},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2377507984638214},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.11558139324188232}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007117","descriptor_name":"Immunization, Secondary","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018023","descriptor_name":"HIV Seronegativity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1093/cid/ciq160","doi":"https://doi.org/10.1093/cid/ciq160","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciq160","pdf_url":"https://academic.oup.com/cid/article-pdf/52/4/522/13802754/ciq160.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:archive.ugent.be:1114576","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1854/LU-1114576","pdf_url":"https://biblio.ugent.be/publication/1114576/file/1114600.pdf","source":{"id":"https://openalex.org/S4306400478","display_name":"Ghent University Academic Bibliography (Ghent University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32597200","host_organization_name":"Ghent University","host_organization_lineage":["https://openalex.org/I32597200"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISSN: 1058-4838","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3060898","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3060898/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Infect Dis","raw_type":"Text"},{"id":"pmid:21208909","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21208909","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.348.7582","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.348.7582","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/bf/58/Clin_Infect_Dis_2011_Feb_15_52(4)_522-531.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1093/cid/ciq160","doi":"https://doi.org/10.1093/cid/ciq160","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciq160","pdf_url":"https://academic.oup.com/cid/article-pdf/52/4/522/13802754/ciq160.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320322603","display_name":"Universiteit Gent","ror":"https://ror.org/00cv9y106"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2160552893.pdf","grobid_xml":"https://content.openalex.org/works/W2160552893.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1493822493","https://openalex.org/W1592780016","https://openalex.org/W1655510925","https://openalex.org/W1975568458","https://openalex.org/W1979461324","https://openalex.org/W1997910013","https://openalex.org/W2000659418","https://openalex.org/W2008667095","https://openalex.org/W2014154781","https://openalex.org/W2025481552","https://openalex.org/W2055017188","https://openalex.org/W2060828809","https://openalex.org/W2062690077","https://openalex.org/W2063755565","https://openalex.org/W2067422236","https://openalex.org/W2070633997","https://openalex.org/W2084734424","https://openalex.org/W2085802287","https://openalex.org/W2093475848","https://openalex.org/W2103728277","https://openalex.org/W2110382769","https://openalex.org/W2118734585","https://openalex.org/W2120181377","https://openalex.org/W2120772351","https://openalex.org/W2124969212","https://openalex.org/W2127085107","https://openalex.org/W2130768495","https://openalex.org/W2149164390","https://openalex.org/W2152048324","https://openalex.org/W2152091763","https://openalex.org/W2152640863","https://openalex.org/W2153670011","https://openalex.org/W2157034871","https://openalex.org/W2159822385","https://openalex.org/W2160925670","https://openalex.org/W2162891851","https://openalex.org/W2163861382","https://openalex.org/W2168188696","https://openalex.org/W2240372320","https://openalex.org/W2998115530"],"related_works":["https://openalex.org/W2085963422","https://openalex.org/W2047901837","https://openalex.org/W282612089","https://openalex.org/W6991872997","https://openalex.org/W2085802287","https://openalex.org/W2105809563","https://openalex.org/W1966722687","https://openalex.org/W2253654265","https://openalex.org/W2160663355"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"phase":[2],"I/II":[3],"partially":[4],"blinded,":[5],"randomized,":[6],"dose-ranging":[7],"study":[8],"assessed":[9],"the":[10,57,107,116,124,128,132,135,143,153],"safety":[11],"and":[12,44,162,170,212,243,281],"immunogenicity":[13],"of":[14,26,56,183,252],"a":[15,27,180,204,259,277,283],"novel":[16],"human":[17],"immunodeficiency":[18],"virus":[19],"type":[20],"1":[21,77],"(HIV-1)":[22],"vaccine":[23,121,145,255,274,287],"candidate":[24,256],"consisting":[25],"recombinant":[28,58],"fusion":[29],"protein":[30,60],"(F4)":[31],"containing":[32],"4":[33,108,166,236],"HIV-1":[34,160,167,240,254],"clade":[35],"B":[36],"antigens":[37,161,237],"(Gag":[38],"p24,":[39],"Pol":[40],"reverse":[41,197],"transcriptase,":[42],"Nef,":[43],"Gag":[45],"p17)":[46],"adjuvanted":[47,66,125,133],"with":[48,67,71,147,192,218,265,272],"AS01":[49,68],"in":[50,99,123,127,152,216,258,263,270,276,288],"HIV-seronegative":[51],"volunteers.":[52],"Methods.":[53],"Two":[54],"doses":[55],"F4":[59],"(10,":[61],"30,":[62],"or":[63,69,269],"90":[64],"\u03bcg/dose),":[65],"reconstituted":[70],"water":[72],"for":[73],"injection,":[74],"were":[75,92,176,231],"administered":[76],"month":[78],"apart":[79],"to":[80,158,164,179,234],"180":[81],"healthy":[82],"volunteers":[83],"aged":[84],"18-40":[85],"years.":[86],"F4-specific":[87,185],"CD4(+)":[88,172,186,200,227],"T":[89,173,187,201,228],"cell":[90,174,229],"responses":[91,194,230],"measured":[93],"using":[94],"intracellular":[95],"cytokine":[96],"staining":[97],"after":[98,119,142],"vitro":[100],"stimulation":[101],"by":[102],"overlapping":[103],"peptide":[104],"pools":[105],"covering":[106],"individual":[109],"antigens.":[110],"Results.":[111],"Reactogenicity":[112],"was":[113,140],"higher":[114],"during":[115],"7-day":[117],"period":[118],"each":[120],"dose":[122],"than":[126],"nonadjuvanted":[129],"groups.":[130],"In":[131],"groups,":[134],"overall":[136],"immune":[137],"response":[138],"rate":[139],"high":[141],"second":[144],"dose,":[146],"highest":[148],"responder":[149],"rates":[150],"seen":[151],"10-\u03bcg":[154],"F4/AS01":[155],"group":[156],"(100%":[157],"3":[159],"80%":[163],"all":[165,235],"antigens).":[168],"High":[169],"long-lasting":[171],"frequencies":[175],"observed":[177],"(up":[178],"median":[181],"value":[182],"1.2%":[184],"cells":[188,202],"at":[189,208],"day":[190],"44),":[191],"strongest":[193],"directed":[195],"against":[196],"transcriptase.":[198],"Antigen-specific":[199],"exhibited":[203],"polyfunctional":[205],"phenotype,":[206],"expressing":[207],"least":[209],"CD40":[210],"ligand":[211],"interleukin":[213],"2,":[214],"often":[215],"combination":[217,271],"tumor":[219],"necrosis":[220],"factor":[221],"\u03b1":[222],"and/or":[223],"interferon":[224],"\u03b3.":[225],"Vaccine-induced":[226],"broadly":[232],"cross-reactive":[233],"derived":[238],"from":[239],"clades":[241],"A":[242],"C.":[244],"Conclusions.":[245],"These":[246],"results":[247],"support":[248],"further":[249],"clinical":[250],"investigation":[251],"this":[253],"both":[257],"prophylactic":[260],"setting":[261],"(alone,":[262],"conjunction":[264],"an":[266],"envelope-based":[267],"antigen":[268],"other":[273],"approaches":[275],"heterologous":[278],"prime-boost":[279],"regimen)":[280],"as":[282],"potentially":[284],"disease-modifying":[285],"therapeutic":[286],"HIV-1-infected":[289],"subjects.":[290],"CLINICAL":[291],"TRIALS":[292],"REGISTRATION:":[293],"NCT00434512.":[294]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2160552893","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
